{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:08:37Z","timestamp":1771589317018,"version":"3.50.1"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82073338"],"award-info":[{"award-number":["No. 82073338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["No.2024YFFK0338"],"award-info":[{"award-number":["No.2024YFFK0338"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["No. 2023YFS0319"],"award-info":[{"award-number":["No. 2023YFS0319"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["No 2022YFS0217"],"award-info":[{"award-number":["No 2022YFS0217"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence","award":["No. ZYAI24045"],"award-info":[{"award-number":["No. ZYAI24045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12149-025-02143-3","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:12:50Z","timestamp":1766139170000},"page":"108-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical utility and future directions of FDG-PET in rectal cancer management"],"prefix":"10.1007","volume":"40","author":[{"given":"Shiyuan","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3599-6904","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"4","key":"2143_CR1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2214\/AJR.18.19620","volume":"211","author":"JJ Bailey","year":"2018","unstructured":"Bailey JJ, Jordan EJ, Burke C, Ohliger MA, Wang ZJ, Van Loon K, et al. Does extended PET acquisition in PET\/MRI rectal cancer staging improve results? AJR Am J Roentgenol. 2018;211(4):896\u2013900.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"2143_CR2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/RLU.0000000000003132","volume":"45","author":"AM Maffione","year":"2020","unstructured":"Maffione AM, Montesi G, Caroli P, Colletti PM, Rubello D, Matteucci F. Is it time to introduce PET\/CT in rectal cancer guidelines? Clin Nucl Med. 2020;45(8):611\u20137.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"2143_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13014-018-1154-3","volume":"13","author":"L Deantonio","year":"2018","unstructured":"Deantonio L, Caroli A, Puta E, Ferrante D, Apicella F, Turri L, Sacchetti G, Brambilla M, Krengli M. Does baseline [18F] FDG-PET\/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Radiat Oncol. 2018;13(1):211.","journal-title":"Radiat Oncol"},{"issue":"11","key":"2143_CR4","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3748\/wjg.v17.i11.1427","volume":"17","author":"PP Mainenti","year":"2011","unstructured":"Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L. Colorectal cancer and 18FDG-PET\/CT: what about adding the T to the N parameter in loco-regional staging? World J Gastroenterol. 2011;17(11):1427\u201333.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"2143_CR5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jso.26602","volume":"124","author":"Y Todate","year":"2021","unstructured":"Todate Y, Honda M, Takada T, Saginoya T, Yamaguchi H, Hamada K, et al. The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: a prospective lymph node level analysis. J Surg Oncol. 2021;124(7):1085\u201390.","journal-title":"J Surg Oncol"},{"issue":"6","key":"2143_CR6","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00261-023-04140-4","volume":"49","author":"W Ma","year":"2024","unstructured":"Ma W, Chen B, Zhu F, Yang C, Yang J. Diagnostic role of F-18 FDG PET\/CT in determining preoperative lymph node status of patients with rectal cancer: a meta-analysis. Abdom Radiol (NY). 2024;49(6):2125\u201334.","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"2143_CR7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejso.2021.12.019","volume":"48","author":"A Agrawal","year":"2022","unstructured":"Agrawal A, Kazi M, Gori J, Dev I, Rangarajan V, Veer A, Patil P, Engineer R, Desouza A, Saklani A. Prospective study to assess the role of FDG PET\/CT in detecting systemic metastatic spread in rectal cancers with lateral pelvic lymph nodes. Eur J Surg Oncol. 2022;48(5):1093\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"2143_CR8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.prro.2013.09.002","volume":"4","author":"JT Whaley","year":"2014","unstructured":"Whaley JT, Fernandes AT, Sackmann R, Plastaras JP, Teo BK, Grover S, et al. Clinical utility of integrated positron emission tomography\/computed tomography imaging in the clinical management and radiation treatment planning of locally advanced rectal cancer. Pract Radiat Oncol. 2014;4(4):226\u201332.","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"2143_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40644-018-0137-9","volume":"18","author":"M Hotta","year":"2018","unstructured":"Hotta M, Minamimoto R, Yano H, Gohda Y, Shuno Y. Diagnostic performance of 18F-FDG PET\/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET\/CT and pelvic MRI. Cancer Imaging. 2018;18(1):4.","journal-title":"Cancer Imaging"},{"issue":"1","key":"2143_CR10","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/s41598-019-41422-8","volume":"9","author":"SH Kim","year":"2019","unstructured":"Kim SH, Song BI, Kim BW, Kim HW, Won KS, Bae SU, et al. Predictive value of [18F]FDG PET\/CT for lymph node metastasis in rectal cancer. Sci Rep. 2019;9(1):4979.","journal-title":"Sci Rep"},{"issue":"1","key":"2143_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40644-018-0165-5","volume":"18","author":"SU Bae","year":"2018","unstructured":"Bae SU, Won KS, Song BI, Jeong WK, Baek SK, Kim HW. Accuracy of F-18 FDG PET\/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer. Cancer Imaging. 2018;18(1):32.","journal-title":"Cancer Imaging"},{"issue":"4","key":"2143_CR12","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/j.ijrobp.2011.03.031","volume":"81","author":"M Br\u00e6ndengen","year":"2011","unstructured":"Br\u00e6ndengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET\/CT: a prospective study. Int J Radiat Oncol Biol Phys. 2011;81(4):e439\u201345.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2143_CR13","doi-asserted-by":"crossref","first-page":"714948","DOI":"10.3389\/fonc.2021.714948","volume":"11","author":"N Zhou","year":"2021","unstructured":"Zhou N, Guo X, Sun H, Yu B, Zhu H, Li N, Yang Z. The value of 18F-FDG PET\/CT and abdominal PET\/MRI as a One-Stop protocol in patients with potentially resectable colorectal liver metastases. Front Oncol. 2021;11:714948.","journal-title":"Front Oncol"},{"issue":"4","key":"2143_CR14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00259-020-05036-x","volume":"48","author":"OA Catalano","year":"2021","unstructured":"Catalano OA, Lee SI, Parente C, Cauley C, Furtado FS, Striar R, Soricelli A, Salvatore M, Li Y, Umutlu L, Ca\u00f1amaque LG, Groshar D, Mahmood U, Blaszkowsky LS, Ryan DP, Clark JW, Wo J, Hong TS, Kunitake H, Bordeianou L, Berger D, Ricciardi R, Rosen B. Improving staging of rectal cancer in the pelvis: the role of PET\/MRI. Eur J Nucl Med Mol Imaging. 2021;48(4):1235\u201345.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2143_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00259-022-05936-0","volume":"50","author":"A Herold","year":"2022","unstructured":"Herold A, Wassipaul C, Weber M, Lindenlaub F, Rasul S, Stift A, Stift J, Mayerhoefer ME, Hacker M, Ba-Ssalamah A, Haug AR, Tamandl D. Added value of quantitative, multiparametric 18F-FDG PET\/MRI in the locoregional staging of rectal cancer. Eur J Nucl Med Mol Imaging. 2022;50(1):205\u201317.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2143_CR16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00259-020-04911-x","volume":"48","author":"MA Queiroz","year":"2021","unstructured":"Queiroz MA, Ortega CD, Ferreira FR, Nahas SC, Cerri GG, Buchpiguel CA. Diagnostic accuracy of FDG-PET\/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients. Eur J Nucl Med Mol Imaging. 2021;48(1):186\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2143_CR17","first-page":"49","volume":"50","author":"HZ Lo","year":"2025","unstructured":"Lo HZ, Choy KT, Kong JCH. FDG-PET\/MRI in colorectal cancer care: an updated systematic review. Abdom Radiol (NY). 2025;50(1):49\u201363.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"2143_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00384-025-04998-4","volume":"40","author":"R Maksim","year":"2025","unstructured":"Maksim R, Buczy\u0144ska A, Sidorkiewicz I, Mojsak M, \u015aliwowska-Burzy\u0144ska J, Zuzda K, Gugnacki P, Kr\u0119towski A, Sierko E. Standard of practice imaging vs. PET\/MR: a comparative prospective study in rectal cancer staging. Int J Colorectal Dis. 2025;40(1):198.","journal-title":"Int J Colorectal Dis"},{"issue":"10","key":"2143_CR19","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3390\/jcm9103163","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, Mueller LI, Neuhaus JP, Bertram S, Schaarschmidt BM, Demircioglu A, et al. 18F-FDG PET\/MR versus MR alone in whole-body primary staging and restaging of patients with rectal cancer: what is the benefit of PET? J Clin Med. 2020;9(10):3163.","journal-title":"J Clin Med"},{"issue":"2","key":"2143_CR20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/bjs.6866","volume":"97","author":"MH Kam","year":"2010","unstructured":"Kam MH, Wong DC, Siu S, Stevenson AR, Lai J, Phillips GE. Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer. Br J Surg. 2010;97(2):266\u20138.","journal-title":"Br J Surg"},{"issue":"11","key":"2143_CR21","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1007\/s00261-019-02089-x","volume":"44","author":"TA Hope","year":"2019","unstructured":"Hope TA, Kassam Z, Loening A, McNamara MM, Paspulati R. The use of PET\/MRI for imaging rectal cancer. Abdom Radiol (NY). 2019;44(11):3559\u201368.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"2143_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/RLU.0000000000001172","volume":"41","author":"M Cerny","year":"2016","unstructured":"Cerny M, Dunet V, Prior JO, Hahnloser D, Wagner AD, Meuli RA, et al. Initial staging of locally advanced rectal cancer and regional lymph nodes: comparison of diffusion-weighted MRI with 18F-FDG-PET\/CT. Clin Nucl Med. 2016;41(4):289\u201395.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"2143_CR23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12149-021-01580-0","volume":"35","author":"F Crim\u00ec","year":"2021","unstructured":"Crim\u00ec F, Valeggia S, Baffoni L, Stramare R, Lacognata C, Spolverato G, Albertoni L, Spimpolo A, Evangelista L, Zucchetta P, Cecchin D, Pucciarelli S. [18F]FDG PET\/MRI in rectal cancer. Ann Nucl Med. 2021;35(3):281\u201390.","journal-title":"Ann Nucl Med"},{"issue":"3","key":"2143_CR24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2967\/jnumed.115.158808","volume":"57","author":"C Spick","year":"2016","unstructured":"Spick C, Herrmann K, Czernin J. 18F-FDG PET\/CT and PET\/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients. J Nucl Med. 2016;57(3):420\u201330.","journal-title":"J Nucl Med"},{"issue":"4","key":"2143_CR25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00261-016-0985-3","volume":"42","author":"OA atalano","year":"2017","unstructured":"atalano OA, Coutinho AM, Sahani DV, Vangel MG, Gee MS, Hahn PF, Witzel T, Soricelli A, Salvatore M, Catana C, Mahmood U, Rosen BR, Gervais D. Colorectal cancer staging: comparison of whole-body PET\/CT and PET\/MR. Abdom Radiol (NY). 2017;42(4):1141\u201351.","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"2143_CR26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00261-015-0474-0","volume":"40","author":"RM Paspulati","year":"2015","unstructured":"Paspulati RM, Partovi S, Herrmann KA, Krishnamurthi S, Delaney CP, Nguyen NC. Comparison of hybrid FDG PET\/MRI compared with PET\/CT in colorectal cancer staging and restaging: a pilot study. Abdom Imaging. 2015;40(6):1415\u201325.","journal-title":"Abdom Imaging"},{"issue":"1","key":"2143_CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40644-019-0237-1","volume":"19","author":"MK Ruteg\u00e5rd","year":"2019","unstructured":"Ruteg\u00e5rd MK, B\u00e5tsman M, Axelsson J, Brynolfsson P, Br\u00e4nnstr\u00f6m F, Ruteg\u00e5rd J, Ljuslinder I, Blomqvist L, Palmqvist R, Ruteg\u00e5rd M, Riklund K. PET\/MRI and PET\/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal cancer trial on PET\/MRI\/CT) study. Cancer Imaging. 2019;19(1):52.","journal-title":"Cancer Imaging"},{"issue":"12","key":"2143_CR28","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1007\/s00259-022-05871-0","volume":"49","author":"SA Mirshahvalad","year":"2022","unstructured":"Mirshahvalad SA, Hinzpeter R, Kohan A, Anconina R, Kulanthaivelu R, Ortega C, et al. Diagnostic performance of [18F]-FDG PET\/MR in evaluating colorectal cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2022;49(12):4205\u201317.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2143_CR29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2010.11.018","volume":"98","author":"J Buijsen","year":"2011","unstructured":"Buijsen J, van den Bogaard J, Janssen MH, Bakers FC, Engelsman S, \u00d6llers M, et al. FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer. Radiother Oncol. 2011;98(2):270\u20136.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2143_CR30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.radonc.2011.12.016","volume":"102","author":"J Buijsen","year":"2012","unstructured":"Buijsen J, van den Bogaard J, van der Weide H, Engelsman S, van Stiphout R, Janssen M, et al. FDG-PET-CT reduces the interobserver variability in rectal tumor delineation. Radiother Oncol. 2012;102(3):371\u20136.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2143_CR31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.21873\/invivo.13095","volume":"37","author":"C Rosa","year":"2023","unstructured":"Rosa C, Gasparini L, DI Guglielmo FC, Caravatta L, DI Tommaso M, Pizzi AD, et al. DWI-MR and PET-CT functional imaging for boost tumor volume delineation in neoadjuvant rectal cancer treatment. In Vivo. 2023;37(1):424\u201332.","journal-title":"In Vivo"},{"key":"2143_CR32","volume":"145","author":"SJ Lee","year":"2021","unstructured":"Lee SJ, Ha S, Pahk K, Choi YY, Choi JY, Kim S, et al. Changes in treatment intent and target definition for preoperative radiotherapy after <Superscript>18<\/Superscript>F-fluorodeoxyglucose positron emission tomography in rectal cancer: a meta-analysis. Eur J Radiol. 2021;145:110061.","journal-title":"Eur J Radiol"},{"issue":"2","key":"2143_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2011.04.004","volume":"99","author":"J van den Bogaard","year":"2011","unstructured":"van den Bogaard J, Janssen MH, Janssens G, Buijsen J, Reniers B, Lambin P, et al. Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer. Radiother Oncol. 2011;99(2):137\u201341.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2143_CR34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12094-016-1522-0","volume":"19","author":"F Alongi","year":"2017","unstructured":"Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-Levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. Clin Transl Oncol. 2017;19(2):189\u201396.","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"2143_CR35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00259-022-05944-0","volume":"50","author":"A Guido","year":"2023","unstructured":"Guido A, Cuicchi D, Castellucci P, Cellini F, Di Fabio F, Llimpe FLR, Strigari L, Buwenge M, Cilla S, Deodato F, Macchia G, Galietta E, Golfieri R, Ardizzoni A, Zagari RM, Fanti S, Poggioli G, Fuccio L, Morganti AG. Adaptive individualized high-dose preoperative (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial. Eur J Nucl Med Mol Imaging. 2023;50(2):572\u201380.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2143_CR36","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/annonc\/mdq433","volume":"22","author":"AA Martoni","year":"2011","unstructured":"Martoni AA, Di Fabio F, Pinto C, Castellucci P, Pini S, Ceccarelli C, et al. Prospective study on the FDG-PET\/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer. Ann Oncol. 2011;22(3):650\u20136.","journal-title":"Ann Oncol"},{"issue":"1","key":"2143_CR37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.radonc.2010.10.012","volume":"98","author":"MS Yoon","year":"2011","unstructured":"Yoon MS, Ahn SJ, Nah BS, Chung WK, Song JY, Jeong JU, Nam TK. The metabolic response using 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography and the change in the carcinoembryonic antigen level for predicting response to pre-operative chemoradiotherapy in patients with rectal cancer. Radiother Oncol. 2011;98(1):134\u20138.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2143_CR38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/DCR.0000000000000959","volume":"61","author":"T Okuno","year":"2018","unstructured":"Okuno T, Kawai K, Koyama K, Takahashi M, Ishihara S, Momose T, Morikawa T, Fukayama M, Watanabe T. Value of FDG-PET\/CT volumetry after chemoradiotherapy in rectal cancer. Dis Colon Rectum. 2018;61(3):320\u20137.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"2143_CR39","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s00330-019-06638-2","volume":"30","author":"NW Schurink","year":"2020","unstructured":"Schurink NW, Min LA, Berbee M, van Elmpt W, van Griethuysen JJM, Bakers FCH, Roberti S, van Kranen SR, Lahaye MJ, Maas M, Beets GL, Beets-Tan RGH, Lambregts DMJ. Value of combined multiparametric MRI and FDG-PET\/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Eur Radiol. 2020;30(5):2945\u201354.","journal-title":"Eur Radiol"},{"issue":"7","key":"2143_CR40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MNM.0000000000001703","volume":"44","author":"FA Vuijk","year":"2023","unstructured":"Vuijk FA, Feshtali Shahbazi S, Noortman WA, van Velden FHP, Dibbets-Schneider P, Marinelli AWKS, Neijenhuis PA, Schmitz R, Ghariq E, Velema LA, Peters FP, Smit F, Peeters KCMJ, Temmink SJD, Crobach SALP, Putter H, Vahrmeijer AL, Hilling DE, de Geus-Oei LF. Baseline and early digital [ 18 F]FDG PET\/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study. Nucl Med Commun. 2023;44(7):613\u201321.","journal-title":"Nucl Med Commun"},{"issue":"6","key":"2143_CR41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00259-013-2357-3","volume":"40","author":"AM Maffione","year":"2013","unstructured":"Maffione AM, Ferretti A, Grassetto G, Bellan E, Capirci C, Chondrogiannis S, Gava M, Marzola MC, Rampin L, Bondesan C, Colletti PM, Rubello D. Fifteen different 18F-FDG PET\/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Eur J Nucl Med Mol Imaging. 2013;40(6):853\u201364.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2143_CR42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00261-009-9594-8","volume":"36","author":"L Guerra","year":"2011","unstructured":"Guerra L, Niespolo R, Di Pisa G, Ippolito D, De Ponti E, Terrevazzi S, Bovo G, Sironi S, Gardani G, Messa C. Change in glucose metabolism measured by 18F-FDG PET\/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer. Abdom Imaging. 2011;36(1):38\u201345.","journal-title":"Abdom Imaging"},{"issue":"7","key":"2143_CR43","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1245\/s10434-012-2248-z","volume":"19","author":"S Shanmugan","year":"2012","unstructured":"Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET\/CT. Ann Surg Oncol. 2012;19(7):2178\u201385.","journal-title":"Ann Surg Oncol"},{"key":"2143_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1748-717X-5-119","volume":"5","author":"P Palma","year":"2010","unstructured":"Palma P, Conde-Mu\u00ed\u00f1o R, Rodr\u00edguez-Fern\u00e1ndez A, Segura-Jim\u00e9nez I, S\u00e1nchez-S\u00e1nchez R, Mart\u00edn-Cano J, G\u00f3mez-R\u00edo M, Ferr\u00f3n JA, Llamas-Elvira JM. The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer. Radiat Oncol. 2010;5:119.","journal-title":"Radiat Oncol"},{"issue":"2","key":"2143_CR45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijrobp.2010.11.038","volume":"82","author":"MH Janssen","year":"2012","unstructured":"Janssen MH, \u00d6llers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, Lambin P, Lammering G. PET-based treatment response evaluation in rectal cancer: prediction and validation. Int J Radiat Oncol Biol Phys. 2012;82(2):871\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2143_CR46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2009.04.030","volume":"77","author":"MH Janssen","year":"2010","unstructured":"Janssen MH, Ollers MC, Riedl RG, van den Bogaard J, Buijsen J, van Stiphout RG, Aerts HJ, Lambin P, Lammering G. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys. 2010;77(2):392\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"2143_CR47","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1245\/s10434-011-1634-2","volume":"18","author":"T Leibold","year":"2011","unstructured":"Leibold T, Akhurst TJ, Chessin DB, Yeung HW, Macapinlac H, Shia J, Minsky BD, Saltz LB, Riedel E, Mazumdar M, Paty PB, Weiser MR, Wong WD, Larson SM, Guillem JG. Evaluation of \u00b9\u2078F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Ann Surg Oncol. 2011;18(10):2783\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2143_CR48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00259-014-2820-9","volume":"42","author":"L Leccisotti","year":"2015","unstructured":"Leccisotti L, Gambacorta MA, de Waure C, Stefanelli A, Barbaro B, Vecchio FM, Coco C, Persiani R, Crucitti A, Tortorelli AP, Giordano A, Valentini V. The predictive value of 18F-FDG PET\/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy. Eur J Nucl Med Mol Imaging. 2015;42(5):657\u201366.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2143_CR49","first-page":"e231","volume":"15","author":"W Sun","year":"2013","unstructured":"Sun W, Xu J, Hu W, Zhang Z, Shen W. The role of sequential 18(F) -FDG PET\/CT in predicting tumour response after preoperative chemoradiation for rectal cancer. Colorectal Dis. 2013;15(5):e231\u20138.","journal-title":"Colorectal Dis"},{"issue":"6","key":"2143_CR50","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00261-024-04689-8","volume":"50","author":"S Chandola","year":"2025","unstructured":"Chandola S, Soni A, Banerjee S, Bhattacharjee HK, Sharma R, Phulia A, Pathy S, Das CJ. Comparison of intravoxel incoherent motion and diffusion kurtosis imaging and 18- FDG PET\/CT in response assessment in rectosigmoid carcinoma. Abdom Radiol (NY). 2025;50(6):2339\u201350.","journal-title":"Abdom Radiol (NY)"},{"issue":"11","key":"2143_CR51","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2967\/jnumed.118.222604","volume":"60","author":"A Avallone","year":"2019","unstructured":"Avallone A, Aloj L, Pecori B, Carac\u00f2 C, De Stefano A, Tatangelo F, et al. <Superscript>18<\/Superscript>F-FDG PET\/CT is an early predictor of pathologic tumor response and survival after preoperative radiochemotherapy with bevacizumab in high-risk locally advanced rectal cancer. J Nucl Med. 2019;60(11):1560\u20138.","journal-title":"J Nucl Med"},{"issue":"6","key":"2143_CR52","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00261-011-9839-1","volume":"37","author":"D Ippolito","year":"2012","unstructured":"Ippolito D, Monguzzi L, Guerra L, Deponti E, Gardani G, Messa C, Sironi S. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET\/CT. Abdom Imaging. 2012;37(6):1032\u201340.","journal-title":"Abdom Imaging"},{"issue":"1","key":"2143_CR53","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1186\/s12885-025-14659-y","volume":"25","author":"F Aras","year":"2025","unstructured":"Aras F, Parvizi M, Nalbant OA, Ozkol V, Kut E. Evaluation of pre-treatment F-18 FDG PET\/CT according to Mandard classification in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapy. BMC Cancer. 2025;25(1):1262.","journal-title":"BMC Cancer"},{"issue":"5","key":"2143_CR54","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00280-013-2114-0","volume":"71","author":"SJ Lee","year":"2013","unstructured":"Lee SJ, Kim JG, Lee SW, Chae YS, Kang BW, Lee YJ, Park JS, Choi GS. Clinical implications of initial FDG-PET\/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Cancer Chemother Pharmacol. 2013;71(5):1201\u20137.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2143_CR55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijrobp.2019.01.077","volume":"104","author":"D Yan","year":"2019","unstructured":"Yan D, Chen S, Krauss DJ, Chen PY, Chinnaiyan P, Wilson GD. Tumor voxel dose-response matrix and dose prescription function derived using 18F-FDG PET\/CT images for adaptive dose painting by number. Int J Radiat Oncol Biol Phys. 2019;104(1):207\u201318.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2143_CR56","volume":"44","author":"GU Erdem","year":"2025","unstructured":"Erdem GU, Vural Topuz O, Acar E, Kapagan T, Yetim E, Ozmen A, et al. Predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: the role of baseline volumetric 18F-FDG PET\/CT parameters and inflammatory markers. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025;44(5):500113.","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"issue":"12","key":"2143_CR57","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/RLU.0000000000000917","volume":"40","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Chang S. Volumetric parameters changes of sequential 18F-FDG PET\/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. Clin Nucl Med. 2015;40(12):930\u20135.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"2143_CR58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13014-025-02703-x","volume":"20","author":"Y Kundel","year":"2025","unstructured":"Kundel Y, Cohen Z, Gordon N, Sulkes A, Morgenstern S, Perl G, et al. Early prediction of histopathological response of locally advanced rectal cancer after 1 week of preoperative radiochemotherapy using 18FDG PET-CT imaging: a prospective clinical validation study. Radiat Oncol. 2025;20(1):121.","journal-title":"Radiat Oncol"},{"issue":"2","key":"2143_CR59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2009.12.033","volume":"94","author":"MH Janssen","year":"2010","unstructured":"Janssen MH, Ollers MC, van Stiphout RG, Buijsen J, van den Bogaard J, de Ruysscher D, et al. Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings. Radiother Oncol. 2010;94(2):151\u20135.","journal-title":"Radiother Oncol"},{"issue":"12","key":"2143_CR60","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s00259-012-2229-2","volume":"39","author":"A Avallone","year":"2012","unstructured":"Avallone A, Aloj L, Carac\u00f2 C, Delrio P, Pecori B, Tatangelo F, Scott N, Casaretti R, Di Gennaro F, Montano M, Silvestro L, Budillon A, Lastoria S. Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome. Eur J Nucl Med Mol Imaging. 2012;39(12):1848\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2143_CR61","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/0284186X.2012.702923","volume":"52","author":"M Hatt","year":"2013","unstructured":"Hatt M, van Stiphout R, le Pogam A, Lammering G, Visvikis D, Lambin P. Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET. Acta Oncol. 2013;52(3):619\u201326.","journal-title":"Acta Oncol"},{"key":"2143_CR62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1748-717X-7-124","volume":"7","author":"N Goldberg","year":"2012","unstructured":"Goldberg N, Kundel Y, Purim O, Bernstine H, Gordon N, Morgenstern S, et al. Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18F-FDG PET-CT imaging. A prospective clinical study. Radiat Oncol. 2012;7:124.","journal-title":"Radiat Oncol"},{"issue":"10","key":"2143_CR63","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ejso.2014.06.005","volume":"40","author":"AM Maffione","year":"2014","unstructured":"Maffione AM, Chondrogiannis S, Capirci C, Galeotti F, Fornasiero A, Crepaldi G, Grassetto G, Rampin L, Marzola MC, Rubello D. Early prediction of response by \u00b9\u2078F-FDG PET\/CT during preoperative therapy in locally advanced rectal cancer: a systematic review. Eur J Surg Oncol. 2014;40(10):1186\u201394.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"2143_CR64","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2214\/AJR.14.13210","volume":"204","author":"AM Maffione","year":"2015","unstructured":"Maffione AM, Marzola MC, Capirci C, Colletti PM, Rubello D. Value of (18)F-FDG PET for predicting response to neoadjuvant therapy in rectal cancer: systematic review and meta-analysis. AJR Am J Roentgenol. 2015;204(6):1261\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2143_CR65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.radonc.2014.11.002","volume":"113","author":"RG van Stiphout","year":"2014","unstructured":"van Stiphout RG, Valentini V, Buijsen J, Lammering G, Meldolesi E, van Soest J, et al. Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: a multicentric prospective study with external validation. Radiother Oncol. 2014;113(2):215\u201322.","journal-title":"Radiother Oncol"},{"issue":"9","key":"2143_CR66","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/DCR.0000000000000655","volume":"59","author":"DA Dos Anjos","year":"2016","unstructured":"Dos Anjos DA, Perez RO, Habr-Gama A, S\u00e3o Juli\u00e3o GP, Vailati BB, Fernandez LM, et al. Semiquantitative volumetry by sequential PET\/CT may improve prediction of complete response to neoadjuvant chemoradiation in patients with distal rectal cancer. Dis Colon Rectum. 2016;59(9):805\u201312.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"2143_CR67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00259-012-2257-y","volume":"40","author":"MJ Murcia Dur\u00e9ndez","year":"2013","unstructured":"Murcia Dur\u00e9ndez MJ, Frutos Esteban L, Luj\u00e1n J, Frutos MD, Valero G, Navarro Fern\u00e1ndez JL, et al. The value of 18F-FDG PET\/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Nucl Med Mol Imaging. 2013;40(1):91\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2143_CR68","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/DCR.0b013e31820b36f0","volume":"54","author":"JM Yeung","year":"2011","unstructured":"Yeung JM, Kalff V, Hicks RJ, Drummond E, Link E, Taouk Y, Michael M, Ngan S, Lynch AC, Heriot AG. Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome. Dis Colon Rectum. 2011;54(5):518\u201325.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"2143_CR69","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00261-014-0277-8","volume":"40","author":"C Altini","year":"2015","unstructured":"Altini C, Niccoli Asabella A, De Luca R, Fanelli M, Caliandro C, Quartuccio N, et al. Comparison of (18)F-FDG PET\/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Abdom Imaging. 2015;40(5):1190\u2013202.","journal-title":"Abdom Imaging"},{"issue":"5","key":"2143_CR70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/RLU.0000000000001166","volume":"41","author":"B Rymer","year":"2016","unstructured":"Rymer B, Curtis NJ, Siddiqui MR, Chand M. FDG PET\/CT can assess the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy: evidence from meta-analysis and systematic review. Clin Nucl Med. 2016;41(5):371\u20135.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"2143_CR71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10151-021-02440-9","volume":"25","author":"F Crim\u00ec","year":"2021","unstructured":"Crim\u00ec F, Stramare R, Spolverato G, Aldegheri V, Barison A, D\u2019Alimonte L, et al. T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy. Tech Coloproctol. 2021;25(5):569\u201377.","journal-title":"Tech Coloproctol"},{"issue":"5","key":"2143_CR72","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00259-013-2341-y","volume":"40","author":"FA Calvo","year":"2013","unstructured":"Calvo FA, Sole CV, de la Mata D, Cabez\u00f3n L, G\u00f3mez-Esp\u00ed M, Alvarez E, et al. \u00b9\u2078F-FDG PET\/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes. Eur J Nucl Med Mol Imaging. 2013;40(5):657\u201367.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2143_CR73","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.radonc.2010.09.021","volume":"97","author":"FA Calvo","year":"2010","unstructured":"Calvo FA, Cabez\u00f3n L, Gonz\u00e1lez C, Soria A, de la Mata D, G\u00f3mez-Esp\u00ed M, et al. (18)F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: focus on nodal disease characteristics. Radiother Oncol. 2010;97(2):212\u20136.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2143_CR74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijrobp.2010.01.021","volume":"80","author":"H Everaert","year":"2011","unstructured":"Everaert H, Hoorens A, Vanhove C, Sermeus A, Ceulemans G, Engels B, Vermeersch M, Verellen D, Urbain D, Storme G, De Ridder M. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET. Int J Radiat Oncol Biol Phys. 2011;80(1):91\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2143_CR75","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00261-016-0698-7","volume":"41","author":"QW Li","year":"2016","unstructured":"Li QW, Zheng RL, Ling YH, Wang QX, Xiao WW, Zeng ZF, Fan W, Li LR, Gao YH. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study. Abdom Radiol (NY). 2016;41(8):1448\u201355.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"2143_CR76","first-page":"e213","volume":"15","author":"PJ Koo","year":"2016","unstructured":"Koo PJ, Kim SJ, Chang S, Kwak JJ. Interim fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography to predict pathologic response to preoperative chemoradiotherapy and prognosis in patients with locally advanced rectal cancer. Clin Colorectal Cancer. 2016;15(4):e213-9.","journal-title":"Clin Colorectal Cancer"},{"key":"2143_CR77","first-page":"113","volume":"36","author":"PP Bulens","year":"2022","unstructured":"Bulens PP, Smets L, Debucquoy A, Joye I, D\u2019Hoore A, Wolthuis A, Debrun L, Dekervel J, Van Cutsem E, Dresen R, Vandecaveye V, Deroose CM, Sagaert X, Haustermans K. Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study. Clin Transl Radiat Oncol. 2022;36:113\u201320.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"8","key":"2143_CR78","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10151-013-1113-9","volume":"18","author":"RO Perez","year":"2014","unstructured":"Perez RO, Habr-Gama A, S\u00e3o Juli\u00e3o GP, Lynn PB, Sabbagh C, Proscurshim I, Campos FG, Gama-Rodrigues J, Nahas SC, Buchpiguel CA. Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET\/CT imaging. Tech Coloproctol. 2014;18(8):699\u2013708.","journal-title":"Tech Coloproctol"},{"issue":"9","key":"2143_CR79","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00384-013-1657-1","volume":"28","author":"JW Kim","year":"2013","unstructured":"Kim JW, Kim HC, Park JW, Park SC, Sohn DK, Choi HS, Kim DY, Chang HJ, Baek JY, Kim SY, Kim SK, Oh JH. Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy. Int J Colorectal Dis. 2013;28(9):1217\u201324.","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"2143_CR80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jso.21736","volume":"103","author":"H Hur","year":"2011","unstructured":"Hur H, Kim NK, Yun M, Min BS, Lee KY, Keum KC, et al. 18fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer. J Surg Oncol. 2011;103(1):17\u201324.","journal-title":"J Surg Oncol"},{"issue":"14","key":"2143_CR81","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/diagnostics15141800","volume":"15","author":"H Tokmak","year":"2025","unstructured":"Tokmak H, Demir N, \u00c7ulpan HC. Total lesion Glycolysis (TLG) on 18F-FDG PET\/CT as a potential predictor of pathological complete response in locally advanced rectal cancer after total neoadjuvant therapy: A retrospective study. Diagnostics (Basel). 2025;15(14):1800.","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"2143_CR82","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1080\/0284186X.2019.1622774","volume":"58","author":"V Ferri","year":"2019","unstructured":"Ferri V, Vicente Lopez E, Quijano Collazo Y, Caruso R, Duran Gimenez Rico H, Ielpo B, et al. Quantitative analysis of 18-FDG-PET\/MRI to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. A prospective preliminary study. Acta Oncol. 2019;58(9):1246\u20139.","journal-title":"Acta Oncol"},{"issue":"1","key":"2143_CR83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00384-024-04803-8","volume":"40","author":"V Ferri","year":"2025","unstructured":"Ferri V, Vicente E, Quijano Y, Duran H, Diaz E, Fabra I, Malave L, Ruiz P, Ballelli L, Broglio A, Ca\u00f1amaque LG, Segui AV, Due\u00f1as VP, Caruso R. Predicting treatment response and survival in rectal cancer: insights from 18 FDG-PET\/MRI post-neoadjuvant therapy. Int J Colorectal Dis. 2025;40(1):6.","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"2143_CR84","doi-asserted-by":"crossref","first-page":"e0169462","DOI":"10.1371\/journal.pone.0169462","volume":"12","author":"B Pecori","year":"2017","unstructured":"Pecori B, Lastoria S, Carac\u00f2 C, Celentani M, Tatangelo F, Avallone A, et al. Sequential PET\/CT with [18F]-FDG predicts pathological tumor response to preoperative short course radiotherapy with delayed surgery in patients with locally advanced rectal cancer using logistic regression analysis. PLoS One. 2017;12(1):e0169462.","journal-title":"PLoS One"},{"issue":"2","key":"2143_CR85","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2010.05.016","volume":"97","author":"D Mak","year":"2010","unstructured":"Mak D, Joon DL, Chao M, Wada M, Joon ML, See A, Feigen M, Jenkins P, Mercuri A, McNamara J, Poon A, Khoo V. The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer. Radiother Oncol. 2010;97(2):205\u201311.","journal-title":"Radiother Oncol"},{"issue":"11","key":"2143_CR86","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1111\/codi.12295","volume":"15","author":"B Krug","year":"2013","unstructured":"Krug B, Crott R, de Canni\u00e8re L, D\u2019Hondt L, Vander Borght T. A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation. Colorectal Dis. 2013;15(11):e627-33.","journal-title":"Colorectal Dis"},{"issue":"1105","key":"2143_CR87","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190455","volume":"93","author":"S Fernando","year":"2020","unstructured":"Fernando S, Lin M, Pham TT, Chong S, Ip E, Wong K, et al. Prognostic utility of serial <Superscript>18<\/Superscript>F-FDG-PET\/CT in patients with locally advanced rectal cancer who underwent tri-modality treatment. Br J Radiol. 2020;93(1105):20190455.","journal-title":"Br J Radiol"},{"issue":"10","key":"2143_CR88","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2967\/jnumed.124.267581","volume":"65","author":"X Zhang","year":"2024","unstructured":"Zhang X, Lin Z, Feng Y, Lin Z, Tao K, Zhang T, et al. Predicting pathologic complete response in locally advanced rectal cancer with [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and contrast-enhanced MRI: lesion-to-lesion comparison with pathology. J Nucl Med. 2024;65(10):1548\u201356.","journal-title":"J Nucl Med"},{"issue":"2","key":"2143_CR89","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SLA.0b013e318277b625","volume":"258","author":"JG Guillem","year":"2013","unstructured":"Guillem JG, Ruby JA, Leibold T, Akhurst TJ, Yeung HW, Gollub MJ, Ginsberg MS, Shia J, Suriawinata AA, Riedel ER, Mazumdar M, Saltz LB, Minsky BD, Nash GM, Paty PB, Temple LK, Weiser MR, Larson SM. Neither FDG-PET nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study. Ann Surg. 2013;258(2):289\u201395.","journal-title":"Ann Surg"},{"issue":"6","key":"2143_CR90","first-page":"493","volume":"39","author":"HJ Jo","year":"2014","unstructured":"Jo HJ, Kim SJ, Lee HY, Kim IJ. Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET\/CT in patients with surgically resected rectal cancer. Clin Nucl Med. 2014;39(6):493\u20137.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"2143_CR91","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/DCR.0b013e318244a666","volume":"55","author":"JA Ruby","year":"2012","unstructured":"Ruby JA, Leibold T, Akhurst TJ, Shia J, Saltz LB, Mazumdar M, Riedel ER, Larson SM, Guillem JG. FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation. Dis Colon Rectum. 2012;55(4):378\u201386.","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"2143_CR92","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/1751-2980.12174","volume":"15","author":"YL Li","year":"2014","unstructured":"Li YL, Wu LM, Chen XX, Delproposto Z, Hu JN, Xu JR. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET\/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer? J Dig Dis. 2014;15(10):525\u201337.","journal-title":"J Dig Dis"},{"issue":"1","key":"2143_CR93","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2017.06.013","volume":"124","author":"I Joye","year":"2017","unstructured":"Joye I, Debucquoy A, Deroose CM, Vandecaveye V, Cutsem EV, Wolthuis A, et al. Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer. Radiother Oncol. 2017;124(1):104\u20139.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2143_CR94","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.radonc.2014.11.026","volume":"113","author":"I Joye","year":"2014","unstructured":"Joye I, Deroose CM, Vandecaveye V, Haustermans K. The role of diffusion-weighted MRI and (18)F-FDG PET\/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review. Radiother Oncol. 2014;113(2):158\u201365.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2143_CR95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00423-025-03679-8","volume":"410","author":"Y Kariv","year":"2025","unstructured":"Kariv Y, Berkovitz R, El-On R, Barenboim A, Tulchinsky H, Zemel M, Brautbar O, Mirelman D, Pelles-Avraham S, Geva R, Ospovat I, Lahat G, Yuval JB. MRI is more accurate than FDG-PET in assessing complete response in rectal cancer patients after neoadjuvant therapy. Langenbecks Arch Surg. 2025;410(1):106.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"2143_CR96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00432-014-1815-z","volume":"141","author":"JW Huh","year":"2015","unstructured":"Huh JW, Kwon SY, Lee JH, Kim HR. Comparison of restaging accuracy of repeat FDG-PET\/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer. J Cancer Res Clin Oncol. 2015;141(2):353\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"14","key":"2143_CR97","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1002\/cncr.26644","volume":"118","author":"RO Perez","year":"2012","unstructured":"Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Juli\u00e3o GP, Lynn P, Ono CR, Campos FG, Silva e Sousa AH Jr, Imperiale AR, Nahas SC, Buchpiguel CA. Accuracy of positron emission tomography\/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National clinical trial 00254683). Cancer. 2012;118(14):3501\u201311.","journal-title":"Cancer"},{"issue":"3","key":"2143_CR98","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejso.2019.07.012","volume":"46","author":"O Asoglu","year":"2020","unstructured":"Asoglu O, Tokmak H, Bakir B, Demir G, Ozyar E, Atalar B, Goksel S, Koza B, Guven Mert A, Demir A, Guven K. The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: the evaluation of 66 cases. Eur J Surg Oncol. 2020;46(3):402\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"2143_CR99","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/SLA.0b013e3181b91e63","volume":"250","author":"MF Kalady","year":"2009","unstructured":"Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg. 2009;250(4):582\u20139.","journal-title":"Ann Surg"},{"issue":"2","key":"2143_CR100","first-page":"e163","volume":"17","author":"K Kawai","year":"2018","unstructured":"Kawai K, Nozawa H, Hata K, Tanaka T, Nishikawa T, Oba K, Watanabe T. Optimal interval for 18F-FDG-PET after chemoradiotherapy for rectal cancer. Clin Colorectal Cancer. 2018;17(2):e163\u201370.","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"2143_CR101","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ijrobp.2012.01.096","volume":"84","author":"RO Perez","year":"2012","unstructured":"Perez RO, Habr-Gama A, S\u00e3o Juli\u00e3o GP, Gama-Rodrigues J, Sousa AH Jr, Campos FG, Imperiale AR, Lynn PB, Proscurshim I, Nahas SC, Ono CR, Buchpiguel CA. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Int J Radiat Oncol Biol Phys. 2012;84(5):1159\u201365.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2143_CR102","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/RLU.0000000000000693","volume":"40","author":"FY Liu","year":"2015","unstructured":"Liu FY, Yen TC, Wang JY, Yang TS. Early prediction by 18F-FDG PET\/CT for progression-free survival and overall survival in patients with metastatic colorectal cancer receiving third-line cetuximab-based therapy. Clin Nucl Med. 2015;40(3):200\u20135.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"2143_CR103","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00259-016-3577-0","volume":"44","author":"Y Lim","year":"2017","unstructured":"Lim Y, Bang JI, Han SW, Paeng JC, Lee KH, Kim JH, et al. Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenib. Eur J Nucl Med Mol Imaging. 2017;44(5):757\u201364.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"2143_CR104","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.2967\/jnumed.113.119909","volume":"54","author":"S Lastoria","year":"2013","unstructured":"Lastoria S, Piccirillo MC, Carac\u00f2 C, Nasti G, Aloj L, Arrichiello C, de Lutio di Castelguidone E, Tatangelo F, Ottaiano A, Iaffaioli RV, Izzo F, Romano G, Giordano P, Signoriello S, Gallo C, Perrone F. Early PET\/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab. J Nucl Med. 2013;54(12):2062\u20139.","journal-title":"J Nucl Med"},{"issue":"3","key":"2143_CR105","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1097\/RLU.0000000000000265","volume":"39","author":"AM Maffione","year":"2014","unstructured":"Maffione AM, Chondrogiannis S, Marzola MC, Rampin L, Grassetto G, Ferretti A, Bellan E, Capirci C, Colletti PM, Rubello D. Biological target volume overlapping segmentation system method for avoiding false-positive PET findings in assessing response to neoadjuvant chemoradiation therapy in rectal cancer. Clin Nucl Med. 2014;39(3):e215\u20139.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"2143_CR106","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/RLU.0b013e3182a20153","volume":"38","author":"AM Maffione","year":"2013","unstructured":"Maffione AM, Ferretti A, Chondrogiannis S, Rampin L, Marzola MC, Grassetto G, et al. Proposal of a new 18F-FDG PET\/CT predictor of response in rectal cancer treated by neoadjuvant chemoradiation therapy and comparison with PERCIST criteria. Clin Nucl Med. 2013;38(10):795\u20137.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"2143_CR107","first-page":"1412","volume":"42","author":"H Zhuang","year":"2001","unstructured":"Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, Mozley PD, Rossman MD, Albelda SM, Alavi A. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42(9):1412\u20137.","journal-title":"J Nucl Med"},{"issue":"1","key":"2143_CR108","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RLU.0b013e3182639a58","volume":"38","author":"HJ Yoon","year":"2013","unstructured":"Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, Park JW, Chang HJ, Choi HS, Kim DY, Oh JH. New application of dual point 18F-FDG PET\/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Clin Nucl Med. 2013;38(1):7\u201312.","journal-title":"Clin Nucl Med"},{"issue":"12","key":"2143_CR109","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/MNM.0000000000000002","volume":"34","author":"H Choi","year":"2013","unstructured":"Choi H, Yoon HJ, Kim TS, Oh JH, Kim DY, Kim SK. Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes. Nucl Med Commun. 2013;34(12):1166\u201373.","journal-title":"Nucl Med Commun"},{"issue":"9","key":"2143_CR110","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s12149-021-01639-y","volume":"35","author":"SW Lee","year":"2021","unstructured":"Lee SW, Jeong SY, Kim K, Kim SJ. Direct comparison of F-18 FDG PET\/CT and MRI to predict pathologic response to neoadjuvant treatment in locally advanced rectal cancer: a meta-analysis. Ann Nucl Med. 2021;35(9):1038\u201347.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"2143_CR111","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/a-0809-4670","volume":"58","author":"M Cerny","year":"2019","unstructured":"Cerny M, Dunet V, Rebecchini C, Hahnloser D, Prior J, Sempoux C, Schmidt S. Response of locally advanced rectal cancer (LARC) to radiochemotherapy: DW-MRI and multiparametric PET\/CT in correlation with histopathology. Nuklearmedizin. 2019;58(1):28\u201338. English.","journal-title":"Nuklearmedizin"},{"issue":"3","key":"2143_CR112","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/DCR.0000000000001568","volume":"63","author":"F Crim\u00ec","year":"2020","unstructured":"Crim\u00ec F, Spolverato G, Lacognata C, Garieri M, Cecchin D, Urso ED, Zucchetta P, Pucciarelli S, Pomerri F. 18F-FDG PET\/MRI for rectal cancer TNM restaging after preoperative chemoradiotherapy: initial experience. Dis Colon Rectum. 2020;63(3):310\u20138.","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"2143_CR113","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00259-013-2479-7","volume":"40","author":"CV Sole","year":"2013","unstructured":"Sole CV, Calvo FA, Alvarez E, Peligros I, Garcia-Alfonso P, Ferrer C, Ochoa E, Herranz R, Carreras JL. Clinical significance of VEGFR-2 and \u00b9\u2078F-FDG PET\/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy. Eur J Nucl Med Mol Imaging. 2013;40(11):1635\u201344.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"2143_CR114","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1007\/s00259-016-3313-9","volume":"43","author":"CV Sole","year":"2016","unstructured":"Sole CV, Calvo FA, Alvarez E, Carreras JL. Metabolic and molecular relative percentage coreduction in patients with locally advanced rectal cancer treated with neoadjuvant therapy. Eur J Nucl Med Mol Imaging. 2016;43(8):1444\u201352.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"2143_CR115","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1007\/s00330-021-07724-0","volume":"31","author":"NW Schurink","year":"2021","unstructured":"Schurink NW, van Kranen SR, Berbee M, van Elmpt W, Bakers FCH, Roberti S, van Griethuysen JJM, Min LA, Lahaye MJ, Maas M, Beets GL, Beets-Tan RGH, Lambregts DMJ. Studying local tumour heterogeneity on MRI and FDG-PET\/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer. Eur Radiol. 2021;31(9):7031\u20138.","journal-title":"Eur Radiol"},{"issue":"6","key":"2143_CR116","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2967\/jnumed.113.127340","volume":"55","author":"RA Bundschuh","year":"2014","unstructured":"Bundschuh RA, Dinges J, Neumann L, Seyfried M, Zs\u00f3t\u00e9r N, Papp L, Rosenberg R, Becker K, Astner ST, Henninger M, Herrmann K, Ziegler SI, Schwaiger M, Essler M. Textural parameters of tumor heterogeneity in \u00b9\u2078F-FDG PET\/CT for therapy response assessment and prognosis in patients with locally advanced rectal cancer. J Nucl Med. 2014;55(6):891\u20137.","journal-title":"J Nucl Med"},{"issue":"11","key":"2143_CR117","doi-asserted-by":"crossref","first-page":"e0242597","DOI":"10.1371\/journal.pone.0242597","volume":"15","author":"P Martin-Gonzalez","year":"2020","unstructured":"Martin-Gonzalez P, de Mariscal EG, Martino ME, Gordaliza PM, Peligros I, Carreras JL, et al. Association of visual and quantitative heterogeneity of 18F-FDG PET images with treatment response in locally advanced rectal cancer: a feasibility study. PLoS One. 2020;15(11):e0242597.","journal-title":"PLoS One"},{"issue":"3","key":"2143_CR118","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00259-015-3180-9","volume":"43","author":"JI Bang","year":"2016","unstructured":"Bang JI, Ha S, Kang SB, Lee KW, Lee HS, Kim JS, Oh HK, Lee HY, Kim SE. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET\/CT scans in locally advanced rectal cancer. Eur J Nucl Med Mol Imaging. 2016;43(3):422\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2143_CR119","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00259-017-3855-5","volume":"45","author":"P Lovinfosse","year":"2018","unstructured":"Lovinfosse P, Polus M, Van Daele D, Martinive P, Daenen F, Hatt M, Visvikis D, Koopmansch B, Lambert F, Coimbra C, Seidel L, Albert A, Delvenne P, Hustinx R. FDG PET\/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging. 2018;45(3):365\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2143_CR120","doi-asserted-by":"crossref","first-page":"31437","DOI":"10.1038\/s41598-024-83109-9","volume":"14","author":"H Lee","year":"2024","unstructured":"Lee H, Hyun SH, Cho YB, Kim HC, Park HC, Park YS, Choi JY. Prognostic value of pseudotime from texture parameters of FDG PET\/CT in locally advanced rectal cancer with neoadjuvant concurrent chemoradiotherapy. Sci Rep. 2024;14(1):31437.","journal-title":"Sci Rep"},{"issue":"4","key":"2143_CR121","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00259-018-4250-6","volume":"46","author":"V Giannini","year":"2019","unstructured":"Giannini V, Mazzetti S, Bertotto I, Chiarenza C, Cauda S, Delmastro E, et al. Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features. Eur J Nucl Med Mol Imaging. 2019;46(4):878\u201388.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"2143_CR122","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/MNM.0000000000001570","volume":"43","author":"G Capelli","year":"2022","unstructured":"Capelli G, Campi C, Bao QR, Morra F, Lacognata C, Zucchetta P, et al. 18F-FDG-PET\/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy. Nucl Med Commun. 2022;43(7):815\u201322.","journal-title":"Nucl Med Commun"},{"issue":"4","key":"2143_CR123","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1109\/TMI.2017.2771379","volume":"37","author":"S Apeke","year":"2018","unstructured":"Apeke S, Gaubert L, Boussion N, Lambin P, Visvikis D, Rodin V, et al. Multi-scale modeling and oxygen impact on tumor temporal evolution: application on rectal cancer during radiotherapy. IEEE Trans Med Imaging. 2018;37(4):871\u201380.","journal-title":"IEEE Trans Med Imaging"},{"issue":"16","key":"2143_CR124","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1158\/1078-0432.CCR-18-3908","volume":"25","author":"SR Bowen","year":"2019","unstructured":"Bowen SR, Hippe DS, Chaovalitwongse WA, Duan C, Thammasorn P, Liu X, Miyaoka RS, Vesselle HJ, Kinahan PE, Rengan R, Zeng J. Voxel forecast for precision oncology: predicting spatially variant and multiscale cancer therapy response on longitudinal quantitative molecular imaging. Clin Cancer Res. 2019;25(16):5027\u201337.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2143_CR125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/atm.2020.01.107","volume":"8","author":"WC Shen","year":"2020","unstructured":"Shen WC, Chen SW, Wu KC, Lee PY, Feng CL, Hsieh TC, et al. Predicting pathological complete response in rectal cancer after chemoradiotherapy with a random forest using 18F-fluorodeoxyglucose positron emission tomography and computed tomography radiomics. Ann Transl Med. 2020;8(5):207.","journal-title":"Ann Transl Med"},{"issue":"1","key":"2143_CR126","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12967-022-03262-5","volume":"20","author":"L Lv","year":"2022","unstructured":"Lv L, Xin B, Hao Y, Yang Z, Xu J, Wang L, et al. Radiomic analysis for predicting prognosis of colorectal cancer from preoperative 18F-FDG PET\/CT. J Transl Med. 2022;20(1):66.","journal-title":"J Transl Med"},{"issue":"1","key":"2143_CR127","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2010.12.002","volume":"98","author":"RG van Stiphout","year":"2011","unstructured":"van Stiphout RG, Lammering G, Buijsen J, Janssen MH, Gambacorta MA, Slagmolen P, et al. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. Radiother Oncol. 2011;98(1):126\u201333.","journal-title":"Radiother Oncol"},{"issue":"7","key":"2143_CR128","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2967\/jnumed.123.266262","volume":"65","author":"EMM Smeets","year":"2024","unstructured":"Smeets EMM, Trajkovic-Arsic M, Geijs D, Karakaya S, van Zanten M, Brosens LAA, Feuerecker B, Gotthardt M, Siveke JT, Braren R, Ciompi F, Aarntzen EHJG. Histology-Based radiomics for [18F]FDG PET identifies tissue heterogeneity in pancreatic cancer. J Nucl Med. 2024;65(7):1151\u20139.","journal-title":"J Nucl Med"},{"issue":"6","key":"2143_CR129","doi-asserted-by":"crossref","first-page":"e190218","DOI":"10.1148\/ryai.2020190218","volume":"2","author":"W Mu","year":"2020","unstructured":"Mu W, Liang Y, Hall LO, Tan Y, Balagurunathan Y, Wenham R, Wu N, Tian J, Gillies RJ. 18F-FDG PET\/CT habitat radiomics predicts outcome of patients with cervical cancer treated with chemoradiotherapy. Radiol Artif Intell. 2020;2(6):e190218.","journal-title":"Radiol Artif Intell"},{"issue":"5","key":"2143_CR130","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s00259-020-04684-3","volume":"47","author":"P Li","year":"2020","unstructured":"Li P, Wang X, Xu C, Liu C, Zheng C, Fulham MJ, et al. 18F-FDG PET\/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients. Eur J Nucl Med Mol Imaging. 2020;47(5):1116\u201326.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2143_CR131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11547-025-01958-4","volume":"130","author":"L Urso","year":"2025","unstructured":"Urso L, Manco L, Cittanti C, Adamantiadis S, Szilagyi KE, Scribano G, et al. 18F-FDG PET\/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Radiol Med. 2025;130(4):543\u201354.","journal-title":"Radiol Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02143-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:20:21Z","timestamp":1771586421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02143-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2143"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02143-3","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review article does not contain any original data. All data cited in this work are available in the published studies referenced in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}}]}}